A new model of progressive visceral leishmaniasis in hamsters by natural transmission via bites of vector sand flies

Journal of Infectious Diseases

Volumn 207, Issue 8, 2013, Pages 1328-1338

  Aslan, Hamide ^a   Dey, Ranadhir ^b   Meneses, Claudio ^a   Castrovinci, Philip ^a   Jeronimo, Selma Maria Bezerra ^c,d   Oliva, Gætano ^e   Fischer, Laurent ^f   Duncan, Robert C ^b   Nakhasi, Hira L ^b   Valenzuela, Jesus G ^a   Kamhawi, Shaden ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^d National Institute for Science and Technology in Tropical Diseases   (Brazil)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

bite; intracardiac; Leishmania; Lutzomyia longipalpis; sand fly; transmission; vector; visceral leishmaniasis

Indexed keywords

AMASTIGOTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BITE; BODY WEIGHT; CONTROLLED STUDY; DISEASE CARRIER; DISEASE COURSE; DISEASE TRANSMISSION; HAMSTER; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LIVER; LIVER WEIGHT; LUTZOMYIA LONGIPALPIS; MALE; MIDGUT; MOUTH DISEASE; NONHUMAN; PARASITE LOAD; PARASITE TRANSMISSION; PATHOGENESIS; PRIORITY JOURNAL; SKIN DISEASE; SPLEEN WEIGHT; SPLENOMEGALY; TESTIS DISEASE; VISCERAL LEISHMANIASIS; WEIGHT REDUCTION;

ANIMALS; BODY WEIGHT; CRICETINAE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; INSECT BITES AND STINGS; INSECT VECTORS; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MALE; ORGAN SIZE; PARASITE LOAD; PSYCHODIDAE; SPLEEN;

EID: 84874252086     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis932     Document Type: Article

References (36)

1. World Health Organization. Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases. TRS No 949 2010. Geneva: WHO.
2. Bern C, Maguire JH, Alvar J. Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis 2008; 2: e313.
3. Ready PD. Leishmaniasis emergence in Europe. Euro Surveill 2010; 15:19505.
4. Romero GA, Boelaert M. Control of visceral leishmaniasis in Latin America-a systematic review. PLoS Negl Trop Dis 2010; 4:e584.
5. Jamjoom MB, Ashford RW, Bates PA, et al. Leishmania donovani is the only cause of visceral leishmaniasis in East Africa; previous descriptions of L. infantum and "L. archibaldi" from this region are a consequence of convergent evolution in the isoenzyme data. Parasitology 2004; 129:399-409.
6. Garg R, Dube A. Animal models for vaccine studies for visceral leishmaniasis. Indian J Med Res 2006; 123:439-54.
7. Kushawaha PK, Gupta R, Sundar S, Sahasrabuddhe AA, Dube A. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmaniainfected patients/hamsters and protects hamsters against Leishmania challenge. J Immunol 2011; 187:6417-27.
8. Prajapati VK, Awasthi K, Gautam S, et al. Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes. J Antimicrob Chemother 2011; 66:874-9.
9. Selvapandiyan A, Dey R, Nylen S, Duncan R, Sacks D, Nakhasi HL. Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis. J Immunol 2009; 183:1813-20.
10. Samant M, Gupta R, Kumari S, et al. Immunization with the DNAencoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis. J Immunol 2009; 183:470-9.
11. Nieto A, Dominguez-Bernal G, Orden JA, De La Fuente R, Madrid- Elena N, Carrion J. Mechanisms of resistance and susceptibility to experimental visceral leishmaniasis: BALB/c mouse versus Syrian hamster model. Vet Res 2011; 42:39.
12. Peters N, Sacks D. Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunol Rev 2006; 213:159-79.
13. Gomes R, Teixeira C, Teixeira MJ, et al. Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model. Proc Natl Acad Sci U S A 2008; 105:7845-50.
14. da Silva RA, Tavares NM, Costa D, et al. DNA vaccination with KMP11 and Lutzomyia longipalpis salivary protein protects hamsters against visceral leishmaniasis. Acta Trop 2011; 120:185-90.
15. Kamhawi S, Belkaid Y, Modi G, Rowton E, Sacks D. Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies. Science 2000; 290:1351-4.
16. Peters NC, Egen JG, Secundino N, et al. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science 2008; 321:970-4.
17. Peters NC, Kimblin N, Secundino N, Kamhawi S, Lawyer P, Sacks DL. Vector transmission of Leishmania abrogates vaccine-induced protective immunity. PloS Pathog 2009; 5: e1000484
18. Gomes R, Teixeira C, Oliveira F, et al. KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi. PLoS Negl Trop Dis 2012; 6: e1610.
19. Ribeiro JM, Mans BJ, Arca B. An insight into the sialome of bloodfeeding Nematocera. Insect Biochem Mol Biol 2010; 40:767-84.
20. Rogers ME, Ilg T, Nikolaev AV, Ferguson MA, Bates PA. Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG. Nature 2004; 430:463-7.
21. Bethony JM, Cole RN, Guo X, et al. Vaccines to combat the neglected tropical diseases. Immunol Rev 2011; 239:237-70.
22. Rogers ME, Bates PA. Leishmania manipulation of sand fly feeding behavior results in enhanced transmission. PLoS Pathog 2007; 3:e91.
23. Belkaid Y, Mendez S, Lira R, Kadambi N, Milon G, Sacks D. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol 2000; 165:969-77.
24. Kimblin N, Peters N, Debrabant A, et al. Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies. Proc Natl Acad Sci U S A 2008; 105:10125-30.
25. Maia C, Seblova V, Sadlova J, Votypka J, Volf P. Experimental transmission of Leishmania infantum by two major vectors: a comparison between a viscerotropic and a dermotropic strain. PLoS Negl Trop Dis 2011; 5:e1181.
26. Secundino NF, de Freitas VC, Monteiro CC, Pires AC, David BA, Pimenta PF. The transmission of Leishmania infantum chagasi by the bite of the Lutzomyia longipalpis to two different vertebrates. Parasit Vectors 2012; 5:20.
27. Melby PC, Chandrasekar B, Zhao WG, Coe JE. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. J Immunol 2001; 166:1912-20.
28. Mookerjee A, Sen PC, Ghose AC. Immunosuppression in hamsters with progressive visceral leishmaniasis is associated with an impairment of protein kinase C activity in their lymphocytes that can be partially reversed by okadaic acid or anti-transforming growth factor ? antibody. Infect Immun 2003; 71:2439-46.
29. Goto H, Lindoso JA. Immunity and immunosuppression in experimental visceral leishmaniasis. Braz J Med Biol Res 2004; 37:615-23.
30. Osorio EY, Zhao W, Espitia C, et al. Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6- dependent host arginase 1 expression. PLoS Pathog 2012; 8:e1002417.
31. Banerjee S, Ghosh J, Sen S, et al. Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells. Infect Immun 2009; 77:2330-42.
32. Selvapandiyan A, Dey R, Gannavaram S, et al. Immunity to visceral leishmaniasis using genetically defined live-attenuated parasites. J Trop Med 2012; 2012:631460.
33. Titus RG, Marchand M, Boon T, Louis JA. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol 1985; 7:545-55.
34. Belkaid Y, Kamhawi S, Modi G, et al. Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J Exp Med 1998; 188:1941-53.
35. Rogers ME, Sizova OV, Ferguson MAJ, Nikolaev AV, Bates PA. Synthetic glycovaccine protects against the bite of Leishmania-infected sand flies. J Infect Dis 2006; 194:512-8.
36. Kamhawi S. Phlebotomine sand flies and Leishmania parasites: friends or foes?. Trends Parasitol 2006; 22:439-45.